Table 1.
Summary of miRNA in HUVEC exposed to a diabetic environment with and without calcitrol
|
miRNA ID |
Diabetic environment
a
|
Diabetic environment and calcitrol |
||
|---|---|---|---|---|
| Fold change | p-value | Fold change | p-value | |
| hsa-mir-600 |
1.53 |
0.014 |
-1.35 |
0.036 |
| hsa-mir-10b |
1.49 |
0.01 |
-1.31 |
0.032 |
| hsa-mir-640 |
1.31 |
0.006 |
-1.35 |
0.004 |
|
hsa-miR-510 |
1.35 |
0.018 |
-1.49 |
0.03 |
|
hsa-miR-659 |
1.37 |
0.13 |
1.99 |
0.0005 |
| hsa-mir-320e |
1.88 |
0.002 |
-1.12 |
0.19 |
| miR-425-star |
1.8 |
0.01 |
-1.48 |
0.034 |
|
hsa-miR-181c |
-1.15 |
0.14 |
3.26 |
0.01 |
|
hsa-miR-411 |
-1.57 |
0.015 |
2.33 |
0.002 |
| hsa-miR-133b |
-1.73 |
0.002 |
1.19 |
0.056 |
| hsa-miR-613 |
-1.91 |
0.005 |
1.38 |
0.036 |
| hsa-miR-335 |
-1.71 |
0.037 |
1.97 |
0.019 |
| hsa-miR-642 |
-1.48 |
0.006 |
1.23 |
0.036 |
| hsa-miR-670 |
-1.41 |
0.026 |
1.53 |
0.014 |
|
hsa-miR-20b |
-2.62 |
0.072 |
2.86 |
0.09 |
|
hsa-miR-15a |
-4.54 |
0.07 |
3.69 |
0.11 |
| hsa-miR-126 | -1.76 | 0.07 | 1.55 | 0.14 |
a200 μg/ml AGE-HSA and 250 mg/dl glucose vs. control (200 μg/μl HSA and 100 mg/dl glucose).